Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

NCT00331630 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: lapatinib ditosylate
DRUG: paclitaxel albumin-stabilized nanoparticle formulation

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]